Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity

  1. Prithvi Raj
  2. Ekta Rai
  3. Ran Song
  4. Shaheen Khan
  5. Benjamin E Wakeland
  6. Kasthuribai Viswanathan
  7. Carlos Arana
  8. Chaoying Liang
  9. Bo Zhang
  10. Igor Dozmorov
  11. Ferdicia Carr-Johnson
  12. Mitja Mitrovic
  13. Graham B Wiley
  14. Jennifer A Kelly
  15. Bernard R Lauwerys
  16. Nancy J Olsen
  17. Chris Cotsapas
  18. Christine K Garcia
  19. Carol A Wise
  20. John B Harley
  21. Swapan K Nath
  22. Judith A James
  23. Chaim O Jacob
  24. Betty P Tsao
  25. Chandrashekhar Pasare
  26. David R Karp
  27. Quan Zhen Li
  28. Patrick M Gaffney
  29. Edward K Wakeland  Is a corresponding author
  1. University of Texas Southwestern Medical Center, United States
  2. Yale School of Medicine, United States
  3. Oklahoma Medical Research Foundation, United States
  4. Université catholique de Louvain, Belgium
  5. Penn State Medical School, United States
  6. Texas Scottish Rite Hospital for Children, United States
  7. Cincinnati Children's Hospital Medical Center, United States
  8. University of Southern California, United States
  9. University of California, Los Angeles, United States

Abstract

Targeted sequencing of sixteen SLE risk loci among 1349 Caucasian cases and controls produced a comprehensive dataset of the variations causing susceptibility to systemic lupus erythematosus (SLE). Two independent disease association signals in the HLA-D region identified two regulatory regions containing 3562 polymorphisms that modified thirty-seven transcription factor binding sites. These extensive functional variations are a new and potent facet of HLA polymorphism. Variations modifying the consensus binding motifs of IRF4 and CTCF in the XL9 regulatory complex modified the transcription of HLA-DRB1, HLA-DQA1 and HLA-DQB1 in a chromosome-specific manner, resulting in a 2.5-fold increase in the surface expression of HLA-DR and DQ molecules on dendritic cells with SLE risk genotypes, which increases to >4-fold after stimulation. Similar analyses of fifteen other SLE risk loci identified 1206 functional variants tightly linked with disease-associated SNPs and demonstrated that common disease alleles contain multiple causal variants modulating multiple immune system genes.

Article and author information

Author details

  1. Prithvi Raj

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Ekta Rai

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Ran Song

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Shaheen Khan

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Benjamin E Wakeland

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Kasthuribai Viswanathan

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Carlos Arana

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Chaoying Liang

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Bo Zhang

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Igor Dozmorov

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Ferdicia Carr-Johnson

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Mitja Mitrovic

    Department of Neurology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Graham B Wiley

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Jennifer A Kelly

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Bernard R Lauwerys

    Pole de pathologies rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Bruxelles, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  16. Nancy J Olsen

    Division of Rheumatology, Department of Medicine, Penn State Medical School, Hershey, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Chris Cotsapas

    Department of Neurology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Christine K Garcia

    Eugene McDermott Center for Human Growth and Development, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Carol A Wise

    Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. John B Harley

    Cincinnati VA Medical Center, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Swapan K Nath

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Judith A James

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  23. Chaim O Jacob

    Department of Medicine, University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  24. Betty P Tsao

    Department of Medicine, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  25. Chandrashekhar Pasare

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  26. David R Karp

    Rheumatic Diseases Division, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  27. Quan Zhen Li

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  28. Patrick M Gaffney

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  29. Edward K Wakeland

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    For correspondence
    edward.wakeland@utsouthwestern.edu
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Human subjects: All the study subjects gave their written informed consent for the study. All the research protocols and methods employed were approved by UT Southwestern Institutional Review Board.

Copyright

© 2016, Raj et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,907
    views
  • 1,120
    downloads
  • 113
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Prithvi Raj
  2. Ekta Rai
  3. Ran Song
  4. Shaheen Khan
  5. Benjamin E Wakeland
  6. Kasthuribai Viswanathan
  7. Carlos Arana
  8. Chaoying Liang
  9. Bo Zhang
  10. Igor Dozmorov
  11. Ferdicia Carr-Johnson
  12. Mitja Mitrovic
  13. Graham B Wiley
  14. Jennifer A Kelly
  15. Bernard R Lauwerys
  16. Nancy J Olsen
  17. Chris Cotsapas
  18. Christine K Garcia
  19. Carol A Wise
  20. John B Harley
  21. Swapan K Nath
  22. Judith A James
  23. Chaim O Jacob
  24. Betty P Tsao
  25. Chandrashekhar Pasare
  26. David R Karp
  27. Quan Zhen Li
  28. Patrick M Gaffney
  29. Edward K Wakeland
(2016)
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity
eLife 5:e12089.
https://doi.org/10.7554/eLife.12089

Share this article

https://doi.org/10.7554/eLife.12089

Further reading

    1. Genetics and Genomics
    Ximena Corso Diaz, Xulong Liang ... Anand Swaroop
    Research Article

    RNA-binding proteins (RBPs) perform diverse functions including the regulation of chromatin dynamics and the coupling of transcription with RNA processing. However, our understanding of their actions in mammalian neurons remains limited. Using affinity purification, yeast-two-hybrid and proximity ligation assays, we identified interactions of multiple RBPs with neural retina leucine (NRL) zipper, a Maf-family transcription factor critical for retinal rod photoreceptor development and function. In addition to splicing, many NRL-interacting RBPs are associated with R-loops, which form during transcription and increase during photoreceptor maturation. Focusing on DHX9 RNA helicase, we demonstrate that its expression is modulated by NRL and that the NRL–DHX9 interaction is positively influenced by R-loops. ssDRIP-Seq analysis reveals both stranded and unstranded R-loops at distinct genomic elements, characterized by active and inactive epigenetic signatures and enriched at neuronal genes. NRL binds to both types of R-loops, suggesting an epigenetically independent function. Our findings suggest additional functions of NRL during transcription and highlight complex interactions among transcription factors, RBPs, and R-loops in regulating photoreceptor gene expression in the mammalian retina.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Eric V Strobl, Eric Gamazon
    Research Article

    Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.